AHMEDABAD, India--(BUSINESS WIRE)--#ChemiSpA--Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the upcoming launch of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets (mixed ...

Consumers who purchased certain generic prescription drugs between May 2009 and December 2019 are eligible for compensation. The settlement, consisting of a $10 million payment from Heritage ...

Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, following the expiry of its patent. Estimated to significantly cut costs and ...

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary ...

Oct 2 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell cheaper copycat versions of its ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Metoclopramide (Perinorm (10 mg)) is a ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Flunarizine (Flunarin (10 mg)) is a calcium ...

Revelations that AbbVie, the manufacturer of Humira, made more than $100 billion in extra profits by abusing the patent system to delay generic competition has spurred efforts by the Biden ...

Nexus sought to launch first generic version of Melinta's injection of antibiotic Minocin FDA argued public interest in cheaper drug outweighed any harm to Melinta (Reuters) - Drugmaker Nexus ...